Screen Reader Mode Icon
Share your thoughts and insights on how the pharma industry is enabling intelligent, end-to-end visibility and transparency to support business growth and continuous improvement in the pharma supply chain.

Question Title

* 1. What nature of business does your job function fall into?

Question Title

* 2. What region are you responsible for in your role?

Question Title

* 3. How far along is your company in implementing end-to-end visibility channels into your supply chain?

Question Title

* 4. What is your most dominant challenge for improving supply chain transparency? Please select all that apply.

Question Title

* 5. How important is having real-time transparency for each of the following aspects in your supply chain? One being extremely important and ten being the least important.

  1. In-transit shipments
  2. Inventory assessments
  3. Arrival times of customer shipments
  4. Procedure compliances (e.g. adherence to lanes, routes, other SOP procedures)
  5. Freight cost and rate information
  6. Lane performance
  7. Product quality performance issues (e.g. temperature excursions, tampering or damage)
  8. Diverted or stolen goods
  9. Logistic service providers (LSPs) or other trading partner performance
  10. Delays or disruptions due to external events (e.g. Suez Canal, Covid-19, port congestion, weather events, etc.)

Question Title

* 6. What initiatives are you implementing to improve your transparency efforts across your supply chain? Please select all that apply.

Question Title

* 7. How much does your company spend on supply chain visibility solutions per year (US$)?

Question Title

* 8. How would you describe your current set up for logistics and transportation operations? Please select all that apply.

Question Title

* 10. What are your company’s key business initiatives over the next two years for improving supply chain visibility?

0 of 11 answered